ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation

NCT01067820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: RVX000222
DRUG: Placebo RVX000222

Sponsor

Resverlogix Corp

Collaborators

[object Object]